Assignee
KOLLTAN PHARMACEUTICALS INC
US·3 granted patents·2 pending applications·33 citations·filing 2011–2016
Top patents by PatentIndex Score
5 records- 0192US9605081B2Polynucleotides encoding anti-kit antibodiesKOLLTAN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·13 cites·8 claims
- 0290US9334332B2Anti-kit antibodiesKOLLTAN PHARMACEUTICALS INC·Filed 2013·Granted May 10, 2016·14 cites·58 claims
- 0387US10239943B2Treatment of eosinophil or mast cell related disordersKOLLTAN PHARMACEUTICALS INC·Filed 2015·Granted Mar 26, 2019·6 cites·6 claims
- 0443US2017100428A1Regulators of anaplastic lymphoma kinase and uses thereofKOLLTAN PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0537US2013011406A1Anti-kit antibodies and uses thereofKOLLTAN PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →